In children with FOXG1 deletions or intragenic mutations, the recognized clinical core features include microcephaly, developmental delays, severe cognitive disabilities, absence or minimal language development, early-onset dyskinesia and hyperkinetic movements, stereotypies, epilepsy, and cerebral malformation [14,15]. The gene discussed is FOXG1; the disease is Global developmental delay.